<DOC>
	<DOC>NCT00974753</DOC>
	<brief_summary>Evaluate the efficacy of ketorolac 0.5%, a topical non-steroidal anti-inflammatory drug (NSAID), to prevent macular edema after epiretinal membrane surgery. Patients undergoing epiretinal membrane surgery have increased risk of macular swelling which can adversely affect vision. Since post-intraocular surgery inflammation is a contributing factor to macular swelling and loss of vision, NSAID drops may be able to prevent or minimize the deleterious effects of macular swelling after epiretinal membrane surgery.</brief_summary>
	<brief_title>Prophylactic Ketorolac Post Epiretinal Membrane Surgery</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>idiopathic epiretinal membrane diagnosis requiring membrane peel surgery proliferative diabetic retinopathy sickle cell retinopathy radiation retinopathy choroidal folds hypersensitivity or allergy to NSAIDs wet macular degeneration branch retinal vein occlusion (BRVO) central retinal vein occlusion (CRVO) complicated membrane peel surgery</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>epiretinal membrane</keyword>
</DOC>